Yubing Zhou

1.3k total citations
56 papers, 1.0k citations indexed

About

Yubing Zhou is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yubing Zhou has authored 56 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 18 papers in Oncology and 8 papers in Immunology. Recurrent topics in Yubing Zhou's work include Cancer-related Molecular Pathways (6 papers), CAR-T cell therapy research (5 papers) and Immune Cell Function and Interaction (5 papers). Yubing Zhou is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), CAR-T cell therapy research (5 papers) and Immune Cell Function and Interaction (5 papers). Yubing Zhou collaborates with scholars based in China, United States and Germany. Yubing Zhou's co-authors include Zujiang Yu, Zhenfeng Duan, Duolu Li, Chao Han, Francis J. Hornicek, Quancheng Kan, Jacson Shen, Quancheng Kan, Xiaojian Zhang and Qingduan Wang and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Yubing Zhou

54 papers receiving 1.0k citations

Peers

Yubing Zhou
Xi Li China
Qiang Qu China
Jia Xu China
Wanyeon Kim South Korea
Yubing Zhou
Citations per year, relative to Yubing Zhou Yubing Zhou (= 1×) peers Fangfang Liu

Countries citing papers authored by Yubing Zhou

Since Specialization
Citations

This map shows the geographic impact of Yubing Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yubing Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yubing Zhou more than expected).

Fields of papers citing papers by Yubing Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yubing Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yubing Zhou. The network helps show where Yubing Zhou may publish in the future.

Co-authorship network of co-authors of Yubing Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yubing Zhou. A scholar is included among the top collaborators of Yubing Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yubing Zhou. Yubing Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xinru, Yang Meng, Duolu Li, et al.. (2024). Overexpression of miR-506-3p reversed doxorubicin resistance in drug-resistant osteosarcoma cells. Frontiers in Pharmacology. 15. 1303732–1303732. 7 indexed citations
2.
Zhang, Wenda, Xinru Wang, Zhe Fu, et al.. (2023). An ultrasensitive and selective near-infrared fluorescent probe for tracking carboxylesterases with large Stokes shift in living cells and mice. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 308. 123708–123708. 7 indexed citations
3.
Zhang, Wenda, Jingmin Zhang, Chong-Zhen Qin, Xinru Wang, & Yubing Zhou. (2022). A far-red/near-infrared fluorescence probe with large Stokes shift for monitoring butyrylcholinesterase (BChE) in living cells and in vivo. Analytica Chimica Acta. 1235. 340540–340540. 17 indexed citations
4.
Zhang, Mengmeng, et al.. (2021). Metabolite profiling of chondrosarcoma cells: A robust GC-MS method for the analysis of endogenous metabolome. Journal of Chromatography B. 1169. 122606–122606. 1 indexed citations
5.
Zhang, Wenda, Yubing Zhou, Duolu Li, & Ting Ma. (2021). Near-infrared fluorescent probe with large stokes shift for detecting Human Neutrophil elastase in living cells. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 252. 119533–119533. 16 indexed citations
6.
Zhang, Ruyue, et al.. (2021). Identification and Validation of an Autophagy-Related lncRNA Signature for Patients With Breast Cancer. Frontiers in Oncology. 10. 597569–597569. 13 indexed citations
7.
Zhang, Ruyue, et al.. (2021). Biological Roles and Therapeutic Applications of IDH2 Mutations in Human Cancer. Frontiers in Oncology. 11. 644857–644857. 21 indexed citations
8.
Zhou, Yubing, Jacson Shen, Zujiang Yu, et al.. (2018). Expression and therapeutic implications of cyclin-dependent kinase 4 (CDK4) in osteosarcoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(5). 1573–1582. 54 indexed citations
9.
Zhang, Jingmin, Yafeng Wang, Youmei Peng, et al.. (2018). Novel fluoronucleoside analog NCC inhibits lamivudine-resistant hepatitis B virus in a hepatocyte model. The Brazilian Journal of Infectious Diseases. 22(6). 477–486. 2 indexed citations
10.
11.
Han, Chao, Yubing Zhou, Qi An, et al.. (2015). MicroRNA-1 (miR-1) inhibits gastric cancer cell proliferation and migration by targeting MET. Tumor Biology. 36(9). 6715–6723. 60 indexed citations
12.
Li, Jingjing, Yanwei Ye, Min Wang, et al.. (2015). The over-expression of FGFR4 could influence the features of gastric cancer cells and inhibit the efficacy of PD173074 and 5-fluorouracil towards gastric cancer. Tumor Biology. 37(5). 6881–6891. 11 indexed citations
13.
Zhou, Yubing, Chao Han, Duolu Li, et al.. (2015). Cyclin-dependent kinase 11p110 (CDK11p110) is crucial for human breast cancer cell proliferation and growth. Scientific Reports. 5(1). 10433–10433. 52 indexed citations
14.
Qian, Xiaolan, Wei Zhang, Yubing Zhou, et al.. (2014). Dexmedetomidine improves early postoperative cognitive dysfunction in aged mice. European Journal of Pharmacology. 746. 206–212. 77 indexed citations
15.
Wang, Yanfang, Zujiang Yu, Duolu Li, et al.. (2014). Ammonia-induced energy disorders interfere with bilirubin metabolism in hepatocytes. Archives of Biochemistry and Biophysics. 555-556. 16–22. 22 indexed citations
16.
Li, Jingjing, Zu‐Jiang Yu, Duolu Li, et al.. (2014). Hyperammonia induces specific liver injury through an intrinsic Ca2+-independent apoptosis pathway. BMC Gastroenterology. 14(1). 151–151. 15 indexed citations
17.
Peng, Youmei, Ning Wang, Ya-Feng Wang, et al.. (2012). [Correlation between reversing effect of cepharanthine hydrochloride on multidrug resistance and P-glycoprotein expression and function of K562/ADR cells].. PubMed. 47(5). 594–9. 6 indexed citations
18.
Zhou, Yubing, Ya-Feng Wang, Yan Zhang, et al.. (2012). In vitro activity of cepharanthine hydrochloride against clinical wild-type and lamivudine-resistant hepatitis B virus isolates. European Journal of Pharmacology. 683(1-3). 10–15. 49 indexed citations
19.
Zheng, Haitao, Chunyan Wang, Lijian Yang, et al.. (2012). Mutations increased overexpression of Notch1 in T-cell acute lymphoblastic leukemia. Cancer Cell International. 12(1). 13–13. 21 indexed citations
20.
Li, Yangqiu, Shaohua Chen, Lijian Yang, et al.. (2005). Clonal expanded TCR Vβ T cells in patients with APL. Hematology. 10(2). 135–139. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026